{
    "data": [
        {
            "id": "6903af84ecb8a7000145b251",
            "title": "Cigna Forecasts Two-Year Margin Strain In Pharmacy Benefit Unit, Stock Tanks",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Cigna Group</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CI\" target=\"_blank\">CI</a>) stock plunged after the company, during its third-quarter 2025 earnings call, <a href=\"https://finance.yahoo.com/quote/CI/earnings/CI-Q3-2025-earnings_call-342007.html\" rel=\"noreferrer noopener\" target=\"_blank\">said</a> it expects margin pressure within the pharmacy benefit services segment over the next two years.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em>CI stock is showing notable weakness. <a href=\"https://www.benzinga.com/quote/CI\" rel=\"noreferrer noopener\" target=\"_blank\">View the charts here</a></em></strong></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">On Monday, Evernorth, Cigna’s health services division, announced a new rebate-free pharmacy benefit model designed to lower <a href=\"https://www.benzinga.com/pressreleases/25/10/n48427825/evernorth-announces-new-era-of-pharmacy-benefit-services-to-lower-americans-medication-costs\" rel=\"noreferrer noopener\" target=\"_blank\">costs and improve transparency</a>.</p><!--/$--><!--$--><p class=\"block core-block\">Cigna Healthcare will adopt this model for its fully insured lives beginning in 2027. It will become the standard model available for all Evernorth pharmacy benefits clients beginning in 2028. </p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: <a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/09/47457102/analyst-favors-cigna-alignment-healthcare-cautious-on-peers\" rel=\"noreferrer noopener\" target=\"_blank\">Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers</a></em></strong></p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><p class=\"block core-block\">“Given the significant financial and affordability pressures for partners operating heavily in government programs, we have proactively improved the economic terms of the contracts for the benefit of these long-term strategic clients,” the company said during the earnings call on Thursday.</p><!--/$--><!--$--><p class=\"block core-block\">The healthcare company reported third-quarter 2025 revenue of $69.74 billion, beating analyst <a href=\"https://www.benzinga.com/calendars/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">estimates of $67.11 billion</a>.</p><!--/$--><!--$--><p class=\"block core-block\">Third-quarter revenues increased 10% year over year, primarily driven by Evernorth Health Services, which includes growth in existing client relationships and strong specialty pharmacy growth.</p><!--/$--><!--$--><p class=\"block core-block\">The company reported adjusted earnings of $7.83 per share, beating <a href=\"https://www.benzinga.com/pressreleases/25/10/n48520679/the-cigna-group-reports-strong-third-quarter-2025-results-reaffirms-2025-adjusted-eps-outlook\" rel=\"noreferrer noopener\" target=\"_blank\">analysts’ estimates of $7.65</a>.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Adjusted income from operations decreased 1% to $2.09 billion, primarily driven by lower contributions from Cigna Healthcare, partially offset by growth in Specialty &amp; Care Services.</p><!--/$--><!--$--><p class=\"block core-block\">Evernorth Health Services reported third-quarter sales of $60.39 billion, up 15%. Pharmacy Benefit Services sales reached $34.09 billion, and Specialty and Care Services sales reached $26.3 billion.</p><!--/$--><!--$--><p class=\"block core-block\">Cigna Healthcare segment sales decreased 18% to $10.76 billion, primarily reflecting the impact of the Health Care Services Corporation (HCSC) transaction.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Excluding the impact of the HCSC transaction, quarterly revenues would have increased 6%, primarily driven by premium rate increases to cover expected increases in medical costs.</p><!--/$--><!--$--><p class=\"block core-block\">The Cigna Healthcare MCR was 84.8% compared to 82.8% a year ago.</p><!--/$--><!--$--><p class=\"block core-block\">Cigna ended the quarter with a total of 18.06 million medical customers, down from 19.05 million. The total number of customer relationships stood at 182.49 million. Excluding the impact of the HCSC transaction6, total customer relationships5 increased 2% from December 31, 2024. Total pharmacy customers were 122.5 million.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Outlook</h2><!--/$--><!--$--><p class=\"block core-block\">Cigna <a href=\"https://www.benzinga.com/markets/earnings/25/07/46766911/cigna-sees-elevated-cost-trends-to-continue-into-next-year\" rel=\"noreferrer noopener\" target=\"_blank\">reaffirms its fiscal 2025 adjusted</a> income per share guidance of more than $29.60, which is lower than the consensus of $29.63.</p><!--/$--><!--$--><p class=\"block core-block\">The company expects Evernorth’s adjusted income from operations (pre-tax) of at least $7.2 billion, with at least $4.125 billion for Cigna Healthcare.</p><!--/$--><!--$--><p class=\"block core-block\">Cigna Healthcare Medical Care Ratio is expected to be between 83.2% to 84.2%.</p><!--/$--><!--$--><p class=\"block core-block\">During the earnings call, Cigna said that in Evernorth, it expects operating income to be slightly down in 2026.</p><!--/$--><!--$--><p class=\"block core-block\">The specialty and care services business is expected to grow income towards the higher end of its long-term growth target, offset by a decline in pharmacy benefit services.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>CI Price Action:</strong> Cigna Group shares were down 13.35% at $259.19 at the time of publication on Thursday. The stock is trading near its 52-week low of $256.89, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em><a href=\"https://www.benzinga.com/node/48529099\" rel=\"noreferrer noopener\" target=\"_blank\">Mounjaro And Zepbound Power Eli Lilly’s 54% Revenue Jump In Q3, Hikes 2025 Forecast</a></em></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo via Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48539871\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Cigna-Group-Sign-At-The-Headquarters-In-.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48539871/cigna-forecasts-two-year-margin-strain-in-pharmacy-benefit-unit-stock-tanks",
            "pub_date": "2025-10-31 02:33:43",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903b0cdecb8a7000145b2eb",
            "title": "Why Is Alnylam Pharmaceuticals Stock Trading Lower Thursday?",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Alnylam Pharmaceuticals Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ALNY\" target=\"_blank\">ALNY</a>) stock is trading lower after the company <a href=\"https://www.benzinga.com/pressreleases/25/10/b48524021/alnylam-pharmaceuticals-reports-third-quarter-2025-financial-results-and-highlights-recent-period-\" rel=\"noreferrer noopener\" target=\"_blank\">reported third-quarter earnings</a>.</p><!--/$--><!--$--><p class=\"block core-block\">Alnylam also said that it received a subpoena from the U.S. Attorney’s Office for the District of Massachusetts seeking documents about government price reporting for Amvuttra, Onpattro, Oxlumo and Givlaari, including certain fee and discount arrangements with distributors.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>    • ALNY is feeling the pressure from bearish momentum. <a href=\"https://www.benzinga.com/quote/ALNY\" rel=\"noreferrer noopener\" target=\"_blank\">See the market dynamics here.</a></strong></p><!--/$--><!--$--><p class=\"block core-block\">The company reported a third-quarter 2025 adjusted earnings of $2.90, a turnaround from a loss of 50 cents a year ago. Analysts <a href=\"https://www.benzinga.com/calendars/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">estimated earnings of 75 cents</a>.</p><!--/$--><!--$--><p class=\"block core-block\">The company reported quarterly sales of $1.25 billion, up 149% year over year, beating the consensus of $977.79 million.</p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">Total net product revenues increased 103% (+99% at constant currency), primarily due to growth from Amvuttra, driven by increased patient demand, mainly in patients with ATTR amyloidosis with cardiomyopathy in the U.S., which was partially offset by a decrease in Onpattro due to patient switches to Amvuttra, and due to growth from an increased number of patients on Givlaari and Oxlumo.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Also Read: <a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/08/46806080/alnylams-amvuttra-makes-powerful-entrance-eyes-first-line-dominance\" rel=\"noreferrer noopener\" target=\"_blank\">Alnylam’s Amvuttra Makes Powerful Entrance, Eyes First-Line Dominance</a></strong></p><!--/$--><!--$--><p class=\"block core-block\">Amvuttra sales jumped 165% to $685.30 million, Onpattro revenue was down 22% to $39.07 million, Oxlumo sales were +31% to $52.83 million, and Givlaari sales reached $73.87 million, +4% year over year.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">“While only in our second full quarter of the AMVUTTRA ATTR-CM launch, the TTR franchise saw remarkable year-over-year growth. AMVUTTRA’s robust clinical profile, convenient quarterly administration, and broad payer coverage all continue to drive this encouraging pace of uptake and further position Alnylam as a leader in TTR,” said <strong>Yvonne Greenstreet</strong>, Alnylam CEO.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Guidance:  </strong>Alnylam Pharmaceuticals raised fiscal 2025 sales guidance <a href=\"https://www.benzinga.com/markets/earnings/25/07/46772818/alnylam-pharmaceuticals-q2-earnings-crush-estimates-stock-hits-52-week-high-on-upbeat-forecast\" rel=\"noreferrer noopener\" target=\"_blank\">from $3.3 billion-$3.55 billion</a> to $3.6 billion-$3.8 billion compared to the consensus of $3.53 billion.</p><!--/$--><!--$--><p class=\"block core-block\">Total TTR net product revenues (Amvuttra and Onpattro) are expected to be $2.48 billion-$2.53 billion, up from prior guidance of $2.175 billion-$2.275 billion.</p><!--/$--><!--$--><p class=\"block core-block\">Reiterates total rare net product revenues (Givlaari and Oxlumo) of $475 million-$525 million.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">William Blair notes that the “stock is down due to lofty investor expectations heading into the print for Amvuttra sales to exceed $695 million to $700 million (Amvuttra sales were $685.3 million for the quarter).”</p><!--/$--><!--$--><p class=\"block core-block\"><strong>ALNY</strong> <strong>Price Action</strong>: ALNY stock is down 8.05% at $442.81 at publication on Thursday.</p><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/markets/tech/25/10/48521419/tesla-recalls-over-6000-cybertrucks-for-faulty-off-road-lightbar\" rel=\"noreferrer noopener\" target=\"_blank\">Tesla Recalls Over 6,000 Cybertrucks For Faulty Off-Road Lightbar</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: PeopleImages via Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48540016\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/One-Serious-Medical-Scientist-Sitting-At.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48540016/why-is-alnylam-pharmaceuticals-stock-trading-lower-thursday",
            "pub_date": "2025-10-31 02:39:12",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903a925ecb8a7000145ae57",
            "title": "Sectoral Investing: The Route To Targeted Market Opportunities",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">In the ever-evolving landscape of financial markets, one question continues to challenge investors: how do you capture high returns without spreading yourself too thin? The answer, for many seasoned investors, lies in sectoral investing, a strategy that focuses on identifying and investing in industries poised for structural growth.</p><!--/$--><!--$--><p class=\"block core-block\">As Jeff Bezos once said, \"Given a 10 percent chance of a 100 times payoff, you should take that bet every time.\" That philosophy mirrors the essence of sectoral investing, calculated conviction. Instead of diversifying broadly across the market, this approach concentrates on sectors with long-term potential, allowing investors to capitalize on cyclical upswings, policy tailwinds, and innovation-driven momentum.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">But while the rewards can be substantial, success depends on timing, research, and risk management. Here's a closer look at how sectoral investing works, why it's gaining traction, and how investors can navigate this focused yet dynamic strategy.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Understanding Sectoral Investing: Concentrated Conviction</strong></p><!--/$--><!--$--><p class=\"block core-block\">At its core, sectoral investing involves allocating capital to a specific sector, such as technology, energy, pharmaceuticals, or consumer goods, based on the belief that this area will outperform the broader market. It's a targeted way to express a market view or capitalize on macroeconomic trends.</p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><p class=\"block core-block\">For example, investors who recognized the digital transformation wave early in the 2010s and bought into information technology stocks witnessed exponential gains. Similarly, those who spotted renewable energy's rise before global climate policies took center stage have benefited from long-term structural growth.</p><!--/$--><!--$--><p class=\"block core-block\">The concept is straightforward, but its execution demands awareness:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Sector selection</strong> is based on understanding economic cycles and growth drivers.</li>\n<li><strong>Timing</strong> matters; entering too late or exiting too early can dilute potential returns.</li>\n<li><strong>Diversification within the sector</strong> is key to managing risk.</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Ultimately, sectoral investing is not about speculation; it's about strategic focus backed by conviction and analysis.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Why Sectoral Investing Is Gaining Momentum</strong></p><!--/$--><!--$--><p class=\"block core-block\"><strong>1. Opportunity in Specialization</strong></p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Investors are increasingly realizing that broad-market exposure often limits potential upside. By concentrating on specific sectors, they can participate directly in macro themes such as artificial intelligence, defense, healthcare innovation, or green energy, areas expected to drive the next decade of economic growth.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>2. Timing the Market — With Insight, Not Emotion</strong></p><!--/$--><!--$--><p class=\"block core-block\">While timing any investment perfectly is impossible, sector rotation strategies allow investors to position themselves in sectors expected to outperform in certain phases of the economic cycle. For instance:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Defensive sectors</strong> like FMCG and healthcare tend to perform well during downturns.</li>\n<li><strong>Cyclical sectors</strong> such as industrials or automobiles thrive when the economy expands.</li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Understanding where we are in the business cycle allows investors to tactically shift allocations, balancing return potential and downside risk.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>3. The Power of Thematic Alignment</strong></p><!--/$--><!--$--><p class=\"block core-block\">Modern economies evolve around powerful themes, digitalization, sustainability, and urbanization, among them. Sectoral investing aligns portfolios with these long-term structural shifts, allowing investors to capture transformational growth stories early.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>How to Approach Sectoral Investing: Building the Right Framework</strong></p><!--/$--><!--$--><p class=\"block core-block\"><strong>1. Active Sector Selection</strong></p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">For investors who enjoy market research, direct sector selection can be rewarding. It demands monitoring policy changes, global trends, and corporate earnings cycles. For example, identifying how defense spending reforms or electric vehicle subsidies impact specific companies can provide a decisive edge.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>2. Mutual Fund Route: Professional Management with Sector Focus</strong></p><!--/$--><!--$--><p class=\"block core-block\">For those who prefer expert management, sectoral mutual funds offer a more guided approach. Here, professional fund managers identify promising sectors and curate portfolios accordingly. Investors can review the fund’s rationale, track record, and risk profile before committing capital.</p><!--/$--><!--$--><p class=\"block core-block\">This method offers:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Diversification within the chosen sector</strong> mitigates company-specific risks.</li>\n<li><strong>Ease of access</strong> for retail investors.</li>\n<li><strong>Transparency and professional oversight</strong>, ensuring better decision-making discipline.</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><strong>3. Fund-of-Fund Approach: Multi-Sector Flexibility</strong></p><!--/$--><!--$--><p class=\"block core-block\">Another popular route is the fund-of-funds (FoF) model, such as thematic advantage funds. In this approach, fund managers dynamically shift exposure across multiple sectors in response to market conditions. Investors, therefore, gain flexibility and adaptive exposure without needing to time every cycle themselves.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Timing and Risk: The Twin Pillars of Sectoral Success</strong></p><!--/$--><!--$--><p class=\"block core-block\">While sectoral investing offers higher potential returns, it also entails greater risk concentration. Being overexposed to a single sector can amplify losses if conditions turn unfavorable.</p><!--/$--><!--$--><p class=\"block core-block\">Hence, investors should:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Assess entry and exit points carefully</strong>, using both technical and macroeconomic indicators.</li>\n<li><strong>Monitor catalysts in the sector</strong>, government policies, consumer trends, or commodity prices.</li>\n<li><strong>Avoid emotional decisions</strong>, as short-term volatility can distort long-term value.</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Sectoral investing demands patience; returns often compound over extended periods rather than appearing overnight. The payoff, however, can be significant for those who align timing with structural shifts.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Key Takeaway:</strong></p><!--/$--><!--$--><p class=\"block core-block\">Sectoral investing represents the balance between specialization and strategy, a way to harness macro trends while maintaining conviction in specific industries. For investors with the discipline to research and the patience to wait, it can be a powerful tool for long-term wealth creation.</p><!--/$--><!--$--><p class=\"block core-block\">However, it's not a \"set-and-forget\" strategy. Timing matters, diversification within the chosen theme is essential, and continuous review of market conditions is non-negotiable.</p><!--/$--><!--$--><p class=\"block core-block\">For those unsure about managing this independently, sectoral and thematic mutual funds provide access to professional expertise without the burden of daily market tracking.</p><!--/$--><!--$--><p class=\"block core-block\">In essence, sectoral investing isn't about chasing trends; it's about identifying structural opportunities before they become mainstream. In a world where information moves fast and opportunities shift even faster, focus isn't a limitation; it's a strategy.</p><!--/$--><!--$--><p class=\"block core-block\">Sectoral investing allows investors to turn insights into action by capitalizing on emerging industries, innovation cycles, and policy trends. Done right, it can convert focused conviction into lasting financial growth.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.</em></strong></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48538900\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/Opinion/25/10/48538900/sectoral-investing-the-route-to-targeted-market-opportunities",
            "pub_date": "2025-10-31 02:06:32",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903adc1ecb8a7000145b16b",
            "title": "Why Docusign Stock Is Gaining Today?",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Docusign, Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/DOCU\" target=\"_blank\">DOCU</a>) shares rose on Thursday after the company introduced a new way to integrate contract <a href=\"https://www.benzinga.com/pressreleases/25/10/n48531793/docusign-brings-its-leading-contract-ai-to-chatgpt\" rel=\"noreferrer noopener\" target=\"_blank\">management directly into ChatGPT.</a></p><!--/$--><!--$--><p class=\"block core-block\"><strong>    • DOCU is in negative territory. <a href=\"https://www.benzinga.com/quote/DOCU\" rel=\"noreferrer noopener\" target=\"_blank\">Track the action here.</a></strong></p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The move adds document creation and analysis to everyday conversations inside the AI platform, cutting out extra steps and keeping work in one place.</p><!--/$--><!--$--><p class=\"block core-block\">With more than one billion agreements handled each year, Docusign plans to blend its Intelligent Agreement Management tools into ChatGPT through the Model Context Protocol.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Also Read: <a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48536083/meta-stock-has-meaningful-runway-ahead-aggressive-ai-investing-opens-up-new-opportunities\" rel=\"noreferrer noopener\" target=\"_blank\">Meta Stock Has ‘Meaningful Runway Ahead’: Aggressive AI Investing Opens Up ‘New Opportunities’</a></strong></p><!--/$--><!--$--><p class=\"block core-block\">This integration will let users and AI agents draft, review, and send agreements without jumping between apps.</p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Direct Contract Work Inside ChatGPT</strong></h2><!--/$--><!--$--><p class=\"block core-block\">Docusign executives said the goal is simple: contracts should not slow anyone down.</p><!--/$--><!--$--><p class=\"block core-block\">The new feature will allow people to ask ChatGPT to prepare leases, purchase orders, and vendor documents, then send them out for signatures. The workflow aims to trim repetitive tasks and move decisions forward faster.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">“AI is changing how people get work done,” said CEO <strong>Allan Thygesen.</strong> “By bringing Docusign’s end-to-end agreement capabilities and agents into ChatGPT, we will make it easier for anyone to move from conversation to action — securely, intelligently, and with confidence.”</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Built On Open Standards</strong></h2><!--/$--><!--$--><p class=\"block core-block\">The company is creating a connector using the open Model Context Protocol. That connector will link ChatGPT to Docusign’s enterprise-grade Intelligent Agreement Management platform.</p><!--/$--><!--$--><p class=\"block core-block\">The design keeps the cloud tools secure and compliant, which is a major concern for companies that handle sensitive data.</p><!--/$--><!--$--><p class=\"block core-block\">The connector debuted at Docusign Discover, the firm’s annual developer event.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The demonstration showed how developers using OpenAI’s AgentKit can extend IAM features inside ChatGPT for legal teams, procurement departments, and other business workflows.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>DOCU</strong> <strong>Price Action:</strong> Docusign shares are trading higher by 4.31% to $71.96 at publication on Thursday.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48539640\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48531471/powell-taps-the-brakes-in-the-fog-but-traders-keep-hitting-the-gas\" rel=\"noreferrer noopener\" target=\"_blank\">Powell Taps The Brakes In The Fog, But Traders Keep Hitting The Gas</a></strong></li>\n</ul><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Stuttgart--Germany---01-30-2025-Mobile-P.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/25/10/48539640/why-docusign-stock-is-gaining-today",
            "pub_date": "2025-10-31 02:26:13",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903aa79ecb8a7000145af48",
            "title": "Small Cap Stock Rockets: Top 10 IWM Holdings&#39; Eye-Popping Rally",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">The past six months have marked an explosive rally for the top holdings of the<strong> iShares Russell 2000 ETF </strong>(NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/IWM\" target=\"_blank\">IWM</a>), with all of the top 10 holdings posting triple-digit gains and capturing <a href=\"https://www.benzinga.com/markets/market-summary/25/10/48423607/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-88\" target=\"_blank\">retail investors' attention.</a></p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><em>OKLO stock is lower today. </em><a href=\"https://www.benzinga.com/quote/OKLO\" target=\"_blank\"><em>See the real-time price action here. </em></a></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">IWM Top Holdings Rally</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>Bloom Energy Corp. </strong>(NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/BE\" target=\"_blank\">BE</a>) is the <a href=\"https://www.ishares.com/us/products/239710/ishares-russell-2000-etf\" target=\"_blank\">top holding</a> in the IWM and provides solid oxide fuel cells for distributed electricity and green hydrogen production. </p><!--/$--><!--$--><p class=\"block core-block\">Bloom Energy stock has soared more than 615% since April, as breakthrough commercial wins and record <a href=\"https://www.benzinga.com/trading-ideas/movers/25/10/48499866/bloom-energy-stock-hits-all-time-high-whats-going-on\" target=\"_blank\">quarterly revenues</a> put the company in the spotlight for sustainable infrastructure and other growth-focused investors.​</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><strong>Credo Technology Group Holding Ltd. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CRDO\" target=\"_blank\">CRDO</a>) specializes in high-speed connectivity for data centers through active electrical cables and next-gen optical DSPs. Its share price surged by nearly 300% in the period, fueled by massive demand from hyperscalers investing in AI infrastructure.</p><!--/$--><!--$--><div class=\"sc-eQzVdq kfhAgV\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>IonQ, Inc.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/IONQ\" target=\"_blank\">IONQ</a>), a leader in <a href=\"https://www.benzinga.com/markets/tech/25/10/48429846/trumps-quantum-interest-shines-spotlight-on-ibms-revenue-lead\" target=\"_blank\">quantum computing</a>, has seen its shares rocket by more than 120% over the last six months as commercialization and enthusiasm for quantum advantage grow. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Fabrinet</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/FN\" target=\"_blank\">FN</a>) has built solid gains on tech industry tailwinds with its stock rising 114% since April. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Oklo Inc. </strong>(NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/OKLO\" target=\"_blank\">OKLO</a>) is developing advanced nuclear power plants for AI data centers. The super-hot sector has driven gains of nearly 500% in Oklo stock over the past six months. </p><!--/$--><!--$--><p class=\"block core-block\">The rest of the IWM's top 10 holdings have also enjoyed incredible momentum over the past six months. </p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Kratos Defense &amp; Security Solutions, Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/KTOS\" target=\"_blank\">KTOS</a>) – up 164%</li>\n<li><strong>Nextracker Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NXT\" target=\"_blank\">NXT</a>) – up more than 140%</li>\n<li><strong>Rigetti Computing, Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/RGTI\" target=\"_blank\">RGTI</a>) – up 367% </li>\n<li><strong>AeroVironment, Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AVAV\" target=\"_blank\">AVAV</a>) – up more than 140%</li>\n<li><strong>Sterling Infrastructure Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/STRL\" target=\"_blank\">STRL</a>) – up more than 150% since April </li>\n</ul><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">The top 10 IWM holdings show that small-cap disruptors are no longer just speculative plays—they have become retail-investor favorites and vital growth engines for portfolios. </p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48539161\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><a href=\"https://www.benzinga.com/news/politics/25/10/48424060/trumps-white-house-ballroom-donors-include-google-micron-palantir-and-more\" target=\"_blank\"><strong>Trump’s White House Ballroom Donors Include Google, Micron, Palantir and More</strong></a></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/rocket-space-ship-space.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/25/10/48539161/small-cap-stock-rockets-top-10-iwm-holdings-eye-popping-rally",
            "pub_date": "2025-10-31 02:12:13",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}